KFDA to switch its penalty regulations to heavier fines

Published: 2003-06-13 06:58:00

Updated: 2003-06-13 06:58:00

The Korea Food and Drug Administration unveiled its plan that those who will be found to violate the current Pharmaceutical Affairs Law should be subject to heavier fines as implemented in advanced countries instead of business suspension, as the administrative dispositions focusing on as busines...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK